Arch Biopartners Inc.
ACHFF
$1.27
$0.0252.02%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 48.34% | -544.48% | -92.61% | -19.72% | 63.79% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -299.71% | 156.70% | -98.03% | 4,442.31% | -87.30% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -60.63% | 45.98% | -249.43% | 45.89% | -83.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 999.57% | -97.60% | -- | -96.67% | -- |
| Total Debt Repaid | -- | 80.39% | -- | -133.33% | 43.00% |
| Issuance of Common Stock | -- | -- | 495.70% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 191.67% | -2,400.00% | -- | -- |
| Cash from Financing | 5,147.69% | 45.62% | 631.19% | -85.56% | 135.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.55% | 92.89% | -94.67% | -154.13% | -52.21% |